Business Context and Reporting Period
Company: Astrana Health, Inc. (ASTH)
Filing Type: Form 8-K (Current Report)
Date of Report: July 24, 2024
Reporting Period: Event-based report regarding a material definitive agreement entered into on July 24, 2024.
Key Financial Metrics and Transaction Details
This filing reports a strategic acquisition rather than periodic financial results. Key transaction metrics include:
- Aggregate Purchase Price: $37.5 million (subject to customary adjustments).
- Potential Earnout Payments: Up to $21.5 million.
- Total Potential Consideration: Up to $59.0 million.
- Target Entities:
- Collaborative Health Systems, LLC ("CHS") - purchased by Astrana Health, Inc.
- Golden Triangle Physician Alliance ("GTPA") - purchased by ApolloCare Partners of Texas 2 (APT).
- Heritage Physician Networks ("HPN") - purchased by APT.
- Sellers: Universal American Corp. ("UAC"), Heritage Health Systems of Texas, Inc. ("HHSTX"), and Heritage Health Systems, Inc. ("HHS").
- Financial Position: The filing does not provide current revenue, profit, cash flow, debt, or liquidity figures for the Company.
Material Changes and Transaction Status
The primary material change is the entry into a Securities Purchase Agreement to acquire three healthcare entities. The transaction is subject to customary closing conditions, including the receipt of applicable regulatory approvals. Management anticipates the closing will occur before the Company's fiscal year end.
Guidance, Outlook, and Risks
Outlook: The Company expects to close the transaction prior to the end of the fiscal year, pending regulatory approvals.
Risks and Contingencies: The filing highlights several risks associated with the transaction, including:
- Diversion of management attention from ongoing operations.
- Increased costs, fees, and expenses related to the transaction.
- Failure to obtain necessary regulatory approvals in a timely manner or at all.
- Potential disruption to business operations and employee retention.
- Termination of the agreement due to unmet conditions.
- Decline in the market price of common stock if the transaction is not completed.
Investor Verification Checklist
- Verify the final closing date and whether the transaction was completed before the fiscal year end.
- Confirm the receipt of all necessary regulatory approvals.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific representations, warranties, and adjustment mechanisms.
- Monitor future filings for the impact of the acquisition on the Company's consolidated financial statements and debt levels.
- Assess the likelihood of achieving the $21.5 million earnout payments based on future performance metrics defined in the agreement.